Peak Bio (PKBO) Competitors $0.07 0.00 (0.00%) (As of 11/4/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsTrends PKBO vs. ALZN, AEZS, BMRA, CDIO, FBRX, BFRI, HOTH, PRTG, ORGS, and ENSCShould you be buying Peak Bio stock or one of its competitors? The main competitors of Peak Bio include Alzamend Neuro (ALZN), Aeterna Zentaris (AEZS), Biomerica (BMRA), Cardio Diagnostics (CDIO), Forte Biosciences (FBRX), Biofrontera (BFRI), Hoth Therapeutics (HOTH), Portage Biotech (PRTG), Orgenesis (ORGS), and Ensysce Biosciences (ENSC). These companies are all part of the "pharmaceutical products" industry. Peak Bio vs. Alzamend Neuro Aeterna Zentaris Biomerica Cardio Diagnostics Forte Biosciences Biofrontera Hoth Therapeutics Portage Biotech Orgenesis Ensysce Biosciences Peak Bio (NASDAQ:PKBO) and Alzamend Neuro (NASDAQ:ALZN) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, community ranking, analyst recommendations, valuation, profitability, dividends, institutional ownership, media sentiment and earnings. Do institutionals & insiders have more ownership in PKBO or ALZN? 49.6% of Alzamend Neuro shares are held by institutional investors. 19.9% of Peak Bio shares are held by company insiders. Comparatively, 10.6% of Alzamend Neuro shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Does the media refer more to PKBO or ALZN? In the previous week, Peak Bio's average media sentiment score of 0.00 equaled Alzamend Neuro'saverage media sentiment score. Company Overall Sentiment Peak Bio Neutral Alzamend Neuro Neutral Does the MarketBeat Community prefer PKBO or ALZN? Alzamend Neuro received 3 more outperform votes than Peak Bio when rated by MarketBeat users. CompanyUnderperformOutperformPeak BioOutperform Votes1100.00% Underperform VotesNo VotesAlzamend NeuroOutperform Votes4100.00% Underperform VotesNo Votes Do analysts rate PKBO or ALZN? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Peak Bio 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/AAlzamend Neuro 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/A Which has more volatility & risk, PKBO or ALZN? Peak Bio has a beta of 1.56, suggesting that its share price is 56% more volatile than the S&P 500. Comparatively, Alzamend Neuro has a beta of -0.04, suggesting that its share price is 104% less volatile than the S&P 500. Which has stronger valuation & earnings, PKBO or ALZN? Alzamend Neuro has lower revenue, but higher earnings than Peak Bio. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPeak Bio$370K4.38-$12.83M-$0.21-0.33Alzamend NeuroN/AN/A-$9.95MN/AN/A Is PKBO or ALZN more profitable? Company Net Margins Return on Equity Return on Assets Peak BioN/A N/A -253.92% Alzamend Neuro N/A N/A -155.52% SummaryAlzamend Neuro beats Peak Bio on 4 of the 7 factors compared between the two stocks. Ad Porter & CompanyElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to humanity, there is a war being waged on Elon Musk. This war has nothing to do with X, Elon’s stance on immigration. Watch this new documentary and you’ll discover what Elon knows, Get Peak Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for PKBO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PKBO vs. The Competition Export to ExcelMetricPeak BioBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.62M$3.11B$5.01B$8.40BDividend YieldN/A1.76%7.52%4.16%P/E Ratio-0.3315.53128.8716.66Price / Sales4.38311.891,718.3776.45Price / CashN/A144.3536.9133.53Price / Book-0.093.974.595.18Net Income-$12.83M-$42.08M$114.09M$223.67M7 Day PerformanceN/A-0.60%110.31%2.58%1 Month PerformanceN/A8.78%124.28%8.66%1 Year PerformanceN/A28.73%154.64%28.23% Peak Bio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PKBOPeak BioN/A$0.07flatN/AN/A$1.62M$370,000.00-0.333ALZNAlzamend Neuro0.3385 of 5 stars$1.65+4.8%N/A-91.4%$6.40MN/A0.004Negative NewsAEZSAeterna Zentaris1.1817 of 5 stars$3.54-0.3%$60.00+1,595.0%-39.5%$6.35M$2.37M-0.2420News CoverageGap UpBMRABiomerica0.9044 of 5 stars$0.37flatN/A-56.7%$6.26M$5.41M-1.0160Positive NewsGap DownCDIOCardio Diagnostics3.0907 of 5 stars$0.26-8.9%$2.00+684.3%-30.6%$6.11M$20,000.000.007Upcoming EarningsGap DownHigh Trading VolumeFBRXForte Biosciences1.5484 of 5 stars$4.18-6.1%$3.25-22.2%+21,670.8%$6.10MN/A-0.235Upcoming EarningsHigh Trading VolumeBFRIBiofrontera2.3851 of 5 stars$1.09-11.4%$7.00+542.2%-75.5%$6.04M$34.07M-0.1870Gap DownHigh Trading VolumeHOTHHoth Therapeutics3.2869 of 5 stars$0.86+1.2%$3.50+307.0%-31.2%$5.93MN/A-0.534Upcoming EarningsAnalyst ForecastGap UpPRTGPortage Biotech1.6299 of 5 stars$5.58-1.8%$120.00+2,050.5%-85.8%$5.86MN/A-0.126Positive NewsORGSOrgenesis2.7306 of 5 stars$1.20+0.4%N/AN/A$5.76M$530,000.000.00150Upcoming EarningsNews CoverageGap UpENSCEnsysce Biosciences1.0102 of 5 stars$0.65+12.8%N/A-34.3%$5.73M$2.23M-0.2310Gap UpHigh Trading Volume Related Companies and Tools Related Companies ALZN Competitors AEZS Competitors BMRA Competitors CDIO Competitors FBRX Competitors BFRI Competitors HOTH Competitors PRTG Competitors ORGS Competitors ENSC Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:PKBO) was last updated on 11/4/2024 by MarketBeat.com Staff From Our Partners2 sentences that change everything you THOUGHT you knew about tradingIf you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfas...Investing Daily | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredElection warning coming true… If you missed it, my emergency election broadcast is now available - watch it before it's too late.Porter & Company | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredA Totally New ‘Income Coin’Buckle up… Because this might shatter everything you thought you knew about "income trading." In fact, i...Crypto 101 Media | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredA new way to play the AI boom (act before November 19)There's a new way to play the $15 trillion AI boom. And it's so simple - you can do it right now with as li...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Peak Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Peak Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PKBO Stock Alerts